• Western Secondary Antibody Dilution Buffer: Assay Control

  2026-09-07

  Discover how Western Secondary Antibody Dilution Buffer can improve assay consistency when studying NHE1, calcium-dependent ROS, and NLRP3 signaling. This guide connects reagent handling with mechanistic interpretation, control design, and practical Western blot decisions.

• Honokiol Workflows for NF-κB and T-Cell Assays

  2026-09-07

  Use Honokiol to connect NF-κB, oxidative-stress, tumor-angiogenesis, and CD8+ T-cell metabolic assays within one controlled experimental design. The workflow emphasizes solvent control, orthogonal viability measurements, and a hypothesis-driven translation of recent PKM splicing findings.

• ER–Ca2+–Calpain Switch in Starved Bombyx mori

  2026-09-05

  A 2026 study in Bombyx mori identifies an ER-Ca2+-calpain signaling axis that links metabolic depletion to a time-dependent shift from protective autophagy to apoptosis in the insect fat body. Its use of 2-APB to suppress IP3R-associated calcium signaling provides pharmacological support for this mechanism while highlighting the value of temporal calcium measurements in nutritional-stress research.

• PD98059 Workflow for MAPK/ERK Studies

  2026-09-04

  PD98059 provides a reversible way to test whether MEK–ERK signaling drives lipid dysregulation, proliferation, or apoptosis. This workflow translates recent vascular toxicology findings into practical assay design, with concentration planning, temporal sampling, and troubleshooting guidance for reproducible mechanism studies.

• PS Nanoplastics–Cadmium Intestinal Apoptosis Pathway

  2026-09-04

  A 2026 Toxicology study combined a C. elegans model with Caco-2 cells to show that polystyrene nanoplastics and cadmium promote intestinal apoptosis through an IP3R/Ca2+/STAT3 signaling axis. Pharmacological inhibition, including intracellular calcium chelation with BAPTA, reduced apoptosis and supports a calcium-dependent mechanism relevant to environmental co-exposure research.

• Partial BACE Inhibition and Synaptic Transmission

  2026-09-03

  Satir et al. tested whether modest β-secretase inhibition can reduce amyloid-beta secretion without disrupting neuronal communication. Using primary rat cortical cultures, optical electrophysiology, and three BACE inhibitors including Lanabecestat (AZD3293), they found that amyloid-beta reduction below 50% preserved synaptic transmission, whereas stronger inhibition reduced both measures.

• How Cell Divisions Refine Drosophila Tissue Boundaries

  2026-09-03

  The reference study shows that cell division has a context-dependent role at the Drosophila mesectoderm–ectoderm boundary: it can promote mixing when actomyosin tension is lost, yet normally sharpen the interface by increasing ectodermal motility and reducing junctional tension. By combining mathematical modelling, quantitative microscopy, laser ablation, and cell tracking, the work identifies tissue fluidity as an active component of boundary refinement.

• Naftifine HCl: Assay Workflows and Optimization

  2026-09-02

  Naftifine HCl supports mechanism-oriented antifungal screening, from concentration-response assays to sterol-pathway confirmation. This guide emphasizes solvent control, orthogonal readouts, and careful separation between fungal pharmacology and the WNT5a/GSK3/β-catenin muscle biology highlighted in the reference study.

• Tranexamic Acid for Reliable Fibrinolysis Assays

  2026-09-02

  Learn how Tranexamic Acid, SKU B1858, can improve interpretability in plasmin, fibrin, neutrophil-adherence, and related cell-based assays. This scenario-driven guide covers concentration selection, aqueous preparation, controls, data interpretation, and practical vendor evaluation.

• Reparixin: A CXCR1/2 Causality Framework

  2026-09-01

  Reparixin is a CXCR1/2 inhibitor that can separate receptor-dependent signaling from broader extracellular-vesicle and inflammatory effects. This article develops a practical framework for applying the compound to neutrophil, OSCC, and inflammation research without overextending current evidence.

• Myriocin and the Next Phase of Sphingolipid Research

  2026-09-01

  Myriocin is more than a pathway inhibitor: it is a translational probe for testing how sphingolipid flux shapes metabolism, mitochondrial function, cancer cell growth, and immune signaling. New mouse data connect serine palmitoyltransferase inhibition with AMPK–PGC1α activation, offering a strategic framework for study design while highlighting the limits of cross-model translation.

• Sulfo-NHS-Biotin in Single-Cell Translation

  2026-08-31

  A mechanistic and strategic guide to using Sulfo-NHS-Biotin for controlled protein and cell-surface labeling, with a translational framework inspired by capped nanovials and scalable single-cell assays.

• GSH and GSSG Assay Kit for Hypoxic TME

  2026-08-31

  Turn hypoxia and immunometabolism experiments into actionable redox data with paired total glutathione and GSSG measurements. This workflow shows how to preserve samples, separate GSH from GSSG, compare tumor and immune compartments, and troubleshoot matrix-driven assay variability.

• NAD+ Workflows for Stress and Autophagy Assays

  2026-08-30

  Use NAD+ to connect redox state, enzymatic activity, and stress adaptation without treating a metabolic readout as proof of autophagy. This workflow pairs NAD+ measurements with caspase, PARP1, LC3B, ATG7, and H2AX endpoints to improve mechanistic resolution in breast cancer cell models.

• Angiotensin (1-7) Research Workflows

  2026-08-29

  Build reproducible Angiotensin (1-7) assays around Mas receptor biology, peptide stability, and experimentally defined dosing. This guide connects cell, biochemical, and disease-model workflows with practical controls for studying anti-fibrotic, anti-inflammatory, metabolic, and neuroprotective effects.

8540 records 8/570 page Previous Next First page 上5页 678910 下5页 Last page